Table 2.
Baseline 10-year and lifetime risks of cardiovascular disease and indications for antihypertensive medications
| N | DASH + WM | DASH | Usual Care | All | |
|---|---|---|---|---|---|
| Ten-year risk of CVD events (%), mean (SD) | 131 | 5.1 (5.2) | 6.9 (7.9) | 5.2 (5.0) | 5.7 (6.1) |
| Ten-year risk of CVD events >10% (%), mean (SD) | 131 | 5 (11%) | 9 (23%) | 7 (16%) | 21 (16%) |
| Lifetime risk of CVD (%), mean (SD) | 110 | 22.5 (9.1) | 20.9 (9.7) | 20.3 (8.2) | 21.3 (8.9) |
| Lifetime risk of CVD death (%), mean (SD) | 110 | 11.7 (6.0) | 10.9 (6.4) | 10.5 (6.0) | 11.0 (6.1) |
| Indication for BP medication, % (N) | 144 | 25 (51%) | 22 (48%) | 24 (49%) | 71 (49%) |
Abbreviations: BP, blood pressure; CVD, cardiovascular disease; DASH, DASH diet; DASH + WM, DASH diet and weight management; N, number.